The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

Physics can feel inscrutable to students; this lesson helps them understand a graphing problem by analyzing their own ...

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...

Forty years after it opened, Landmark College in Putney, Vermont, remains a haven for students with dyslexia, autism and ADHD.

Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.

Get insights from Vertex Pharmaceuticals' Q3 2025 earnings call—revenue growth, pipeline milestones, and outlook for ALYFTREK, CASGEVY, and JOURNAVX.

This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.

Read about types of businesses, how to start one, and how to get a business loan Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides ...

The quality of an applicant's personal statement is very important at LSE. The School does not interview for places so this is an applicant’s only opportunity to demonstrate they are a good fit for ...